Regarding to the association in this polymorphism with the soluble levels of MIF and TNFα in women with BC significant differences by genotype were not shown, but we observed higher MIF levels in homozygous 7,7 carriers (18.8 ng/mL) in women with BC (Figure 3A). The gene discussed is MIF; the disease is breast cancer.